Explore bonds
Showing 36 bonds
- 1
- 2
Issuer | Yield | Coupon | Price | Maturity | Rating | Liquidity | Type | Callable | ||
|---|---|---|---|---|---|---|---|---|---|---|
![]() | PFE Wyeth Llc | 4.59% | 6.50% | $112.76 | 02/01/2034 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Investment Enterprises Pte Ltd. | 4.54% | 4.75% | $101.27 | 05/19/2033 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 4.44% | 4.50% | $100.38 | 11/15/2032 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Investment Enterprises Pte Ltd. | 4.13% | 4.65% | $102.01 | 05/19/2030 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 4.11% | 4.20% | $100.41 | 11/15/2030 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 4.08% | 2.625% | $94.36 | 04/01/2030 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 4.08% | 1.75% | $88.37 | 08/18/2031 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 4.07% | 1.70% | $90.50 | 05/28/2030 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.99% | 6.60% | $107.15 | 12/01/2028 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Investment Enterprises Pte Ltd. | 3.92% | 4.45% | $101.17 | 05/19/2028 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.86% | 3.45% | $98.76 | 03/15/2029 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.85% | 2.75% | $99.53 | 06/03/2026 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.79% | 3.00% | $99.26 | 12/15/2026 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.77% | 6.75% | $105.62 | 12/15/2027 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.75% | 3.875% | $100.24 | 11/15/2027 | Investment grade | Corporate | Trade | ||
![]() | PFE Pfizer Inc. | 3.69% | 3.60% | $99.76 | 09/15/2028 | Investment grade | Corporate | Trade |
Fixed income data powered by Moment. For more information about trading fixed income products please see our disclosures.

